GlobeNewswire

OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
04/11/2026
Conference Call to Begin Today at 4:30 p.m. ET MIAMI, Nov. 04, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical company, today reports business highlights and financial results [...]
FocalTherics™ to Participate in Upcoming Investor Conferences
04/11/2026
FocalTherics ™ to Participate in Upcoming Investor Conferences AUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/11/2026
MALVERN, Pa., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar ® TMS technology and direct patient care through the Greenbrook [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/11/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 04 nov. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
04/11/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
04/11/2026
Fiscal 2027 second quarter revenue increased 9%; constant currency organic revenue growth was 8% Fiscal 2027 second quarter as reported diluted EPS increased to $2.19; adjusted EPS per diluted share increased to $2.94 [...]
Edesa Biotech to Present at Guggenheim Healthcare Innovation Conference
04/11/2026
TORONTO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today [...]
Eton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London
04/11/2026
DEER PARK, Ill., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Moleculin Announces Acceptance of Annamycin Data for Presentation at the 2026 American Society of Hematology (ASH) Annual Meeting
04/11/2026
First interim results from pivotal Phase 2/3 trial highlight encouraging remission rates in patients with relapsed or refractory AML HOUSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq: MBRX) (“ [...]
Asgard Therapeutics announces publication in Immunity demonstrating induction of cancer-fighting tertiary lymphoid structures across seven tumor types – and will present new AT-108 biomarker data at SITC 2026
04/11/2026
Study in Immunity highlights Asgard's ability to generate potent immunogenic tertiary lymphoid structures (imgTLSs) solely by reprogramming tumor cells into antigen-presenting conventional type 1 dendritic cells (cDC1s [...]
Zelluna ASA awarded NOK 15.6 million Research Council of Norway grant to further advance TCR-NK manufacturing
04/11/2026
Oslo, 4 November 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announced that the [...]
Tessera Therapeutics to Present New Preclinical Data Supporting its In Vivo Sickle Cell Disease Program and In Vivo CAR-T Applications at the 68th American Society of Hematology Annual Meeting
04/11/2026
SOMERVILLE, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Tessera Therapeutics, Inc. (“Tessera”), a clinical-stage biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced [...]
Virbac : Déclaration d'actions et de droits de vote 10/2026
04/11/2026
DÉCLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Virbac : Declaration of the number of shares and voting rights 10/2026
04/11/2026
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Valneva publiera ses résultats financiers consolidés des neuf premiers mois de l’année le 24 novembre 2026
04/11/2026
Lyon (France), le 4 novembre 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui qu’elle publiera ses résultats financiers des neuf premiers mois de l’année [...]
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
04/11/2026
Lyon (France), November 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its nine-month 2026 financial results on Tuesday, November 24, 2026. The [...]
Standard Dental Labs Acquires M&D Dental Arts; Announces December 1 Launch Target for Bridge AI Software
04/11/2026
Acquisition expected to double Orlando laboratory output; internally developed platform connects digital dentistry workflows and lays groundwork for AI-assisted restoration design ORLANDO, Fla., Nov. 04, 2026 (GLOBE [...]
Neion Bio Taps John Maga as Head of Biologics and CMC to Expand Capabilities In Innovative Development
04/11/2026
Veteran biopharmaceutical executive brings deep experience across complex therapeutic modalities as Neion expands the Raptor platform for innovative and difficult-to-express proteins NEW YORK, Nov. 04, 2026 (GLOBE [...]
Pacific Health Care Organization, Inc. Reports its Third Quarter 2026 Financial Results
04/11/2026
Irvine, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum